About Life Sciences Review APAC
Life Sciences Review APAC (Print ISSN 2831-8323 | Digital ISSN 2831-8331) is an industry magazine focused on the APAC life sciences sector, helping organizations navigate a complex landscape shaped by scientific innovation, regulatory rigor, and evolving market dynamics. Founded in 2020, the magazine reaches over 86,000 qualified subscribers across APAC.
At its core, Life Sciences Review APAC operates as a peer-driven platform where industry leaders and decision-makers share real-world insights, challenges, and strategies. The publication emphasizes practical, experience-led perspectives, offering a grounded view of how organizations across pharmaceuticals, biotechnology, medical devices, and diagnostics are adapting to shifting demands and advancing innovation.
OUR Mission
Life Sciences Review APAC aims to empower organizations and industry leaders to make informed decisions on the technologies, strategies, and solutions shaping the future of life sciences. As a knowledge-sharing platform, it bridges the gap between enterprises, solution providers, and stakeholders working to drive scientific progress, efficiency, and regulatory excellence.
Editorial Focus and Coverage
Life Sciences Review APAC features perspectives from executives, researchers, and operational leaders on how organizations evaluate, adopt, and scale solutions across the life sciences ecosystem. The publication covers key areas such as compliance, regulatory affairs, analytics, product design and development, testing and validation, clinical operations, toxicology services, supply chain management, and training.
Alongside leadership insights, the magazine highlights organizations delivering impactful solutions across life sciences technologies and services. Companies are identified through a structured methodology, involving nominations from the publication’s subscriber network across APAC, combined with editorial research and insights from an industry advisory panel, ensuring a credible and balanced view of the evolving ecosystem.
As the industry undergoes a shift toward more specialized, digital, and integrated models, driven by cost pressures, scientific breakthroughs, and changing demographics, Life Sciences Review APAC captures how organizations are building agility and resilience while maintaining a focus on innovation and patient impact.
With editorial offices in Singapore; Fremont, CA; Fort Lauderdale, FL; Brasilia, Brazil; Toronto, Canada and London, UK, Life Sciences Review APAC brings a global perspective to the developments shaping the life sciences industry.

150+ CXOs and senior leaders from public enterprises

750+ CXOs and senior leaders from private companies

Industry leaders responsible for research, clinical operations, regulatory compliance, product development, analytics, and strategic innovation
These contributors include executives, scientists, and operational leaders who bring firsthand experience and practical insight into the evolving life sciences landscape. Their perspectives reflect individual expertise and are intended to inform broader industry conversations.
Life Sciences Review APAC maintains a contributor-driven, insight-focused editorial policy. The publication emphasizes accuracy, clarity, and practical relevance for decision-makers, while presenting a balanced mix of expert commentary and curated industry perspectives. This ensures readers can engage with the content confidently and understand its context within the broader life sciences ecosystem.
seeDNA

“seeDNA was thrilled to be featured in Life Sciences Review APAC, and we’ve been incredibly impressed with the reprints that we’ve received. They’ve been a valuable asset for our sales team, and we’re already seeing an increase in interest from potential clients as a result. We would highly recommend Life Sciences Review APAC to any business looking to gain exposure and establish themselves as a leader in their industry”
Kinori Tomikane, CEOKanwhish Biotech

“Kanwhish Biotech is deeply appreciative of Life Sciences Review APAC for their outstanding feature on our company in their issue. The reprints have played a pivotal role in elevating our company’s profile and bolstering our reputation within the industry. We look forward to future opportunities to collaborate and share our ongoing innovations with Life Sciences Review APAC. Kudos to your entire team for their exceptional work”
Linglong Zou, PhD, CEOHumintech

“We are deeply honored to be featured in Life Science Review APAC and grateful to receive the “Top Smart Digital Biomedical Informatics Solution in Asia 2025” award. Life Sciences review in-depth coverage not only highlighted our work but also amplified our mission to support researchers, clinicians, and industry leaders with cutting- edge technologies. We sincerely appreciate the magazine’s commitment to showcasing organizations that drive scientific and technological progress across Asia.”
Tayyaba Naeem, Research ManagerJW Consulting Engineers

“JW Consulting Engineers was thrilled to be featured in Life Sciences Review, and we’ve been incredibly impressed with the reprints that we’ve received. They’ve been a valuable asset and we have received an increase in interest in our company since the publication came out. We would highly recommend Life Sciences Review to any business looking to gain exposure and establish themselves as a leader in their industry.”
Joseph Winslow, Principal ConsultantPharmaniaga Berhad [KLSE: PHARMA]
Dr. Israfil Merican, MD, MHM, Director of Pharmaniaga Marketing Sdn Bhd
Halal Biopharma: Closing the Therapeutic GapsRegeneron [NASDAQ: REGN]
Yojiro Kamiya, Country Sales Director
A New Paradigm in Pharmaceutical Sales and MarketingTakeda [TYO: 4502]
Jessica Thongcharen, Director Global Patient Safety & Evaluation- Clinical Operations
Smart, Collective Measurement Is Key to Strengthening Healthcare SystemsCSL [ASX: CSL]
Rose Fida, Executive Director, Program & Performance Excellence, Global R&D Portfolio & Operations Excellence
Navigating Global R&D and Pharmacokinetics in OncologyKemin Industries
Yee Wong, R&D Director | Animal Nutrition and Health, Asia Pacific
Comprehensive Biosecurity Containment and Anti-Viral Solutions to Tackling African Swine Fever to Ensure Better Food Security for AsiaServier
Marcia Matos, Clinical Operations HUB Director for APAC
Clinical Trials Landscape in APAC and Its Unique Characteristics and OpportunitiesPierre Fabre Group
Sarah Tregenza, Director of Medical Affairs Oncology (APAC)
Oncology in TransitionDexa Medica
Raymond R. Tjandrawinata, Director of Business Development and Scientific Affairs
Emphasizing the importance of quality assurance in assuring product qualityLife Sciences Review APAC RESEARCH
Advancing Clinical Confidence through ADMET and PKPD Intelligence
Translating Original Biomarkers into Clinical Impact in the Asia-Pacific Region
The Shifting Tides of Drug Discovery: Evolving Pharmacokinetic Strategies in APAC CRO Partnerships
The Strategic Case for an Integrated Life Sciences Marketing Platform
Chitosan's Expanding Frontier: From Smart Wound Care to Cancer Nanocarriers








